Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Merrick

Concepts (332)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
43
2026
2679
2.870
Why?
Precancerous Conditions
13
2026
166
2.510
Why?
Carcinoma, Squamous Cell
15
2024
648
1.850
Why?
Carcinoma, Non-Small-Cell Lung
14
2026
1195
1.330
Why?
Adenocarcinoma
7
2019
928
0.580
Why?
B7-H1 Antigen
3
2026
246
0.440
Why?
Biopsy
9
2026
1093
0.440
Why?
Bronchi
6
2018
263
0.430
Why?
Chemoprevention
4
2019
92
0.410
Why?
Biomarkers, Tumor
9
2026
1339
0.380
Why?
ErbB Receptors
6
2023
638
0.370
Why?
Disease Progression
7
2019
2892
0.360
Why?
Carmustine
3
2020
52
0.360
Why?
Neovascularization, Pathologic
5
2015
287
0.340
Why?
Heat-Shock Proteins
1
2012
140
0.340
Why?
Bronchial Neoplasms
2
2011
15
0.330
Why?
Papillomaviridae
4
1996
116
0.310
Why?
Polymorphism, Genetic
1
2012
615
0.300
Why?
Gene Expression Regulation, Neoplastic
7
2026
1457
0.290
Why?
Smoke
3
2020
148
0.280
Why?
Proto-Oncogene Proteins
3
2018
627
0.280
Why?
Keratinocytes
4
1996
249
0.280
Why?
Lung Diseases
1
2015
787
0.280
Why?
Cell Transformation, Neoplastic
4
2024
340
0.280
Why?
Smoking
6
2019
1483
0.280
Why?
Protein Kinase Inhibitors
4
2026
984
0.280
Why?
Lung
10
2025
4141
0.270
Why?
Gene Dosage
3
2016
145
0.270
Why?
Formaldehyde
2
2025
65
0.260
Why?
Carcinogenesis
2
2020
230
0.250
Why?
Epoprostenol
2
2018
132
0.240
Why?
Inflammation
1
2018
2921
0.240
Why?
Iloprost
4
2018
45
0.240
Why?
Carcinogens
5
2018
123
0.230
Why?
Mice
23
2026
18493
0.230
Why?
Humans
56
2026
147306
0.220
Why?
In Situ Hybridization, Fluorescence
3
2018
330
0.210
Why?
Sputum
4
2019
302
0.210
Why?
Mutation
6
2023
4130
0.200
Why?
Immunohistochemistry
5
2015
1730
0.200
Why?
Mast Cells
1
2025
148
0.200
Why?
Cardiomyopathy, Hypertrophic, Familial
1
2003
15
0.200
Why?
Neoplasm Invasiveness
4
2015
512
0.190
Why?
Chest Pain
1
2003
100
0.190
Why?
Desmoglein 3
2
2022
14
0.190
Why?
Cell Proliferation
4
2018
2529
0.180
Why?
Vascular Endothelial Growth Factor A
1
2005
552
0.180
Why?
Lidocaine
1
2022
55
0.180
Why?
Epithelial-Mesenchymal Transition
3
2022
222
0.180
Why?
Inflammation Mediators
1
2025
507
0.180
Why?
Gelatin
1
2022
56
0.180
Why?
Gene Expression Profiling
3
2026
1794
0.180
Why?
Neuropilin-1
1
2021
8
0.180
Why?
Neoplasms
3
2026
2946
0.180
Why?
Animals
24
2026
38417
0.170
Why?
Male
31
2026
73954
0.170
Why?
Image Processing, Computer-Assisted
1
2026
794
0.170
Why?
Ki-67 Antigen
2
2015
120
0.170
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
87
0.170
Why?
Middle Aged
20
2026
36821
0.160
Why?
Female
31
2026
80081
0.160
Why?
Cysts
1
2021
112
0.160
Why?
Receptor, IGF Type 1
2
2010
64
0.160
Why?
Aged
14
2026
26516
0.150
Why?
Granulomatosis with Polyangiitis
1
2020
47
0.150
Why?
Biomedical Research
1
2026
723
0.150
Why?
Air Pollution
1
2023
315
0.150
Why?
Respiratory System
1
2020
150
0.150
Why?
Carcinoma in Situ
1
2019
46
0.150
Why?
Cell Cycle Proteins
2
2018
633
0.150
Why?
Disease Models, Animal
5
2020
4605
0.150
Why?
Pneumonia
1
2025
636
0.140
Why?
gamma Catenin
1
2018
13
0.140
Why?
Fluorescent Antibody Technique
1
2019
365
0.140
Why?
Air Pollutants
1
2023
407
0.140
Why?
Exons
1
2020
365
0.140
Why?
Metaplasia
1
2018
57
0.140
Why?
Drug Resistance, Neoplasm
3
2023
889
0.140
Why?
Bronchial Diseases
1
2018
38
0.140
Why?
Tobacco Smoke Pollution
1
2020
227
0.140
Why?
MicroRNAs
2
2016
695
0.130
Why?
Mucin 5AC
1
2018
71
0.130
Why?
Anticarcinogenic Agents
1
2018
63
0.130
Why?
Cell Cycle Checkpoints
1
2018
97
0.130
Why?
Urethane
4
2023
43
0.120
Why?
RNA, Messenger
5
2022
2812
0.120
Why?
Cell Transformation, Viral
2
1993
23
0.120
Why?
Aged, 80 and over
7
2017
8432
0.120
Why?
Head and Neck Neoplasms
1
2021
569
0.120
Why?
Frizzled Receptors
1
2016
25
0.120
Why?
Antigen Presentation
1
2017
209
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
156
0.120
Why?
Prognosis
6
2026
4384
0.120
Why?
Oncogene Proteins, Fusion
1
2018
212
0.120
Why?
Porphyrins
1
2015
16
0.110
Why?
Proto-Oncogene Proteins c-met
1
2016
76
0.110
Why?
Oncogenes
1
2016
118
0.110
Why?
Tomography, Spiral Computed
1
2015
30
0.110
Why?
Myocardial Infarction
1
2003
1213
0.110
Why?
Topoisomerase Inhibitors
1
2015
2
0.110
Why?
Adult
13
2026
41406
0.110
Why?
Smad4 Protein
1
2015
34
0.110
Why?
Protein-Tyrosine Kinases
1
2018
432
0.110
Why?
Chromosomal Instability
1
2013
21
0.100
Why?
Macrophages, Alveolar
2
2023
377
0.100
Why?
Mice, Transgenic
5
2018
2197
0.100
Why?
Microarray Analysis
1
2013
117
0.100
Why?
Bronchopulmonary Dysplasia
1
2019
437
0.100
Why?
Neoplasms, Basal Cell
1
2013
4
0.100
Why?
Stem Cells
1
2018
630
0.100
Why?
Obesity
1
2007
3149
0.100
Why?
Trachea
1
2015
258
0.090
Why?
Endoscopy
1
2015
322
0.090
Why?
Interleukin-1
1
1996
961
0.090
Why?
Tretinoin
1
1993
125
0.090
Why?
Quinazolines
2
2012
266
0.090
Why?
Piperidines
2
2012
224
0.090
Why?
Receptors, Transforming Growth Factor beta
1
2012
55
0.090
Why?
B-Lymphocytes
1
2017
878
0.090
Why?
PTEN Phosphohydrolase
1
2013
165
0.090
Why?
Antigens, Differentiation
1
1992
76
0.090
Why?
Cohort Studies
3
2023
6099
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2012
980
0.080
Why?
Cell Line
4
2019
2832
0.080
Why?
Hyperplasia
1
2011
177
0.080
Why?
CD4-Positive T-Lymphocytes
1
2017
1162
0.080
Why?
Tissue Array Analysis
3
2019
49
0.080
Why?
Receptor Protein-Tyrosine Kinases
1
2012
231
0.080
Why?
Epithelium
4
2018
311
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
928
0.080
Why?
Diagnosis, Differential
3
2021
1518
0.080
Why?
Pulmonary Surgical Procedures
1
2010
7
0.080
Why?
Early Detection of Cancer
1
2015
506
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
2001
0.080
Why?
Pulmonary Alveoli
1
2012
389
0.070
Why?
Nuclear Proteins
3
2006
745
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2005
849
0.070
Why?
Vasodilator Agents
1
2011
330
0.070
Why?
Cell Polarity
1
2010
137
0.070
Why?
Small Cell Lung Carcinoma
1
2010
125
0.070
Why?
Epithelial Cells
4
2018
1141
0.070
Why?
Neoplasm Staging
3
2020
1492
0.070
Why?
Receptors, Fibroblast Growth Factor
1
2008
71
0.070
Why?
Follow-Up Studies
2
2015
5478
0.070
Why?
Solitary Fibrous Tumor, Pleural
1
2008
3
0.070
Why?
Osteoarthropathy, Secondary Hypertrophic
1
2008
3
0.070
Why?
Smokers
2
2019
139
0.070
Why?
Echocardiography
2
2003
652
0.070
Why?
Neoplasms, Experimental
2
2018
167
0.060
Why?
Prevalence
3
2023
2889
0.060
Why?
Fibroblast Growth Factors
1
2008
188
0.060
Why?
Carcinoma, Small Cell
1
2008
173
0.060
Why?
Monocytes
1
2010
539
0.060
Why?
Edema
1
2008
128
0.060
Why?
Gene Expression Regulation
1
2016
2625
0.060
Why?
Radiography, Thoracic
1
2008
173
0.060
Why?
Genome-Wide Association Study
1
2013
1496
0.060
Why?
Bronchoalveolar Lavage Fluid
2
2025
641
0.060
Why?
Minichromosome Maintenance Complex Component 2
1
2006
3
0.060
Why?
Placebos
2
2019
193
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2223
0.060
Why?
Hydrogels
2
2023
706
0.060
Why?
Mice, Inbred C57BL
3
2025
6042
0.060
Why?
United Kingdom
1
2007
391
0.060
Why?
Survival Rate
2
2026
2110
0.060
Why?
Biomarkers
4
2023
4354
0.060
Why?
Cell Movement
2
2025
966
0.060
Why?
Mice, Inbred A
2
2020
48
0.060
Why?
Transcription Factors
1
1993
1747
0.060
Why?
Gene Rearrangement
1
2026
156
0.050
Why?
Tumor Microenvironment
2
2021
748
0.050
Why?
Environment
1
2007
297
0.050
Why?
Treatment Outcome
5
2022
11947
0.050
Why?
Chromosome Aberrations
2
2017
168
0.050
Why?
Proto-Oncogene Proteins p21(ras)
2
2018
256
0.050
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
109
0.050
Why?
Specimen Handling
1
2026
183
0.050
Why?
Bronchoscopy
2
2019
228
0.050
Why?
Hypoxia
1
2012
1209
0.050
Why?
Global Health
1
2007
406
0.050
Why?
Prospective Studies
4
2023
8166
0.050
Why?
Japan
1
2003
149
0.050
Why?
Gene Knockdown Techniques
2
2015
334
0.050
Why?
Acrylamides
1
2023
74
0.050
Why?
Keratin-5
1
2022
44
0.050
Why?
Socioeconomic Factors
1
2007
1342
0.040
Why?
Alveolar Epithelial Cells
1
2023
121
0.040
Why?
Aniline Compounds
1
2023
120
0.040
Why?
Up-Regulation
1
2005
848
0.040
Why?
Diagnostic Errors
1
2003
182
0.040
Why?
Immunoenzyme Techniques
2
2012
200
0.040
Why?
Signal Transduction
3
2012
5272
0.040
Why?
Particle Size
1
2023
382
0.040
Why?
Molecular Targeted Therapy
2
2018
444
0.040
Why?
Mice, Inbred BALB C
2
2011
1266
0.040
Why?
Adaptive Immunity
1
2023
171
0.040
Why?
Dendritic Cells
1
2025
510
0.040
Why?
Interferon-gamma
2
2018
786
0.040
Why?
PPAR gamma
1
2022
182
0.040
Why?
Tubulin
1
2022
146
0.040
Why?
Sensitivity and Specificity
1
2006
2017
0.040
Why?
Interleukin-1beta
1
2023
394
0.040
Why?
Double-Blind Method
2
2019
2080
0.040
Why?
Incidence
2
2008
2954
0.040
Why?
Exercise Test
1
2003
636
0.040
Why?
Acute Disease
1
2003
1049
0.040
Why?
Oximes
1
2020
26
0.040
Why?
Particulate Matter
1
2023
329
0.040
Why?
Electrocardiography
1
2003
675
0.040
Why?
Blotting, Western
2
2012
1186
0.040
Why?
Pyrimidinones
1
2020
125
0.040
Why?
Pyrimidines
1
2023
532
0.040
Why?
Amino Acid Substitution
1
2020
303
0.040
Why?
Rituximab
1
2020
211
0.040
Why?
Cell Line, Transformed
2
1996
138
0.040
Why?
Indoles
1
2023
510
0.040
Why?
Imidazoles
1
2020
247
0.030
Why?
RNA
1
2005
916
0.030
Why?
Remission Induction
1
2019
310
0.030
Why?
Tobacco Smoking
1
2018
28
0.030
Why?
T-Lymphocytes, Regulatory
1
2021
415
0.030
Why?
Diagnostic Imaging
1
2021
342
0.030
Why?
Environmental Exposure
1
2023
583
0.030
Why?
Intramolecular Oxidoreductases
1
2018
65
0.030
Why?
Pyridones
1
2020
210
0.030
Why?
Breast Neoplasms
1
2011
2420
0.030
Why?
Tricuspid Valve
1
1998
43
0.030
Why?
Time
1
2018
84
0.030
Why?
Proto-Oncogene Proteins B-raf
1
2020
230
0.030
Why?
Ventricular Outflow Obstruction
1
1998
38
0.030
Why?
RNA, Small Interfering
2
2012
643
0.030
Why?
Cytochrome P-450 Enzyme System
1
2018
163
0.030
Why?
Lymphocyte Count
1
2017
165
0.030
Why?
Risk Factors
3
2019
11017
0.030
Why?
Tumor Burden
1
2018
327
0.030
Why?
DNA Copy Number Variations
1
2018
190
0.030
Why?
Antigen-Presenting Cells
1
2017
161
0.030
Why?
Carcinogenicity Tests
1
1996
13
0.030
Why?
Diabetes Mellitus
1
2006
1107
0.030
Why?
Mass Screening
2
2004
1375
0.030
Why?
Structure-Activity Relationship
1
2018
567
0.030
Why?
Blotting, Northern
1
1996
203
0.030
Why?
Immunotherapy
1
2021
672
0.030
Why?
Cells, Cultured
2
2016
4170
0.030
Why?
Neoplasms, Glandular and Epithelial
1
1996
52
0.030
Why?
Neoplasm Transplantation
1
1996
246
0.030
Why?
Immunophenotyping
1
2017
325
0.030
Why?
Centrosome
1
2016
72
0.030
Why?
Plasmids
1
1996
373
0.030
Why?
Mitotic Index
1
2015
25
0.030
Why?
Smoking Cessation
1
2019
441
0.030
Why?
Mice, Nude
1
1996
680
0.030
Why?
Survival Analysis
1
2018
1386
0.030
Why?
Cell Differentiation
2
1993
2054
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2018
539
0.030
Why?
Phenotype
2
1993
3216
0.030
Why?
Neoplasm Grading
1
2015
313
0.030
Why?
Loss of Heterozygosity
1
2013
52
0.020
Why?
Retinoid X Receptors
1
1993
42
0.020
Why?
Receptors, Retinoic Acid
1
1993
44
0.020
Why?
Lymphocyte Activation
1
2017
1140
0.020
Why?
Uterine Cervical Neoplasms
1
1996
268
0.020
Why?
Organ Culture Techniques
1
1993
154
0.020
Why?
Computational Biology
1
2018
677
0.020
Why?
Drug Resistance
1
1993
145
0.020
Why?
Cytosol
1
1993
213
0.020
Why?
Models, Molecular
1
2018
1606
0.020
Why?
DNA Repair
1
2015
256
0.020
Why?
Methylcholanthrene
1
2012
21
0.020
Why?
Macrophages
1
2020
1530
0.020
Why?
c-Mer Tyrosine Kinase
1
2012
39
0.020
Why?
Butylated Hydroxytoluene
1
2012
37
0.020
Why?
Cell Line, Tumor
2
2012
3565
0.020
Why?
Respiratory Mucosa
1
2015
324
0.020
Why?
Immunoprecipitation
1
2012
149
0.020
Why?
Proliferating Cell Nuclear Antigen
1
1992
48
0.020
Why?
Intermediate Filament Proteins
1
1992
57
0.020
Why?
Receptors, Cytoplasmic and Nuclear
1
1993
212
0.020
Why?
Gene Deletion
1
2013
392
0.020
Why?
Administration, Topical
1
2011
156
0.020
Why?
Keratins
1
1992
171
0.020
Why?
Mutation, Missense
1
2013
337
0.020
Why?
Sleep Apnea Syndromes
1
2012
98
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2012
169
0.020
Why?
United States
2
2011
16313
0.020
Why?
Carcinoma, Large Cell
1
2010
17
0.020
Why?
Cell Division
1
1992
758
0.020
Why?
RNA Interference
1
2012
477
0.020
Why?
Antineoplastic Agents
2
2012
2231
0.020
Why?
Administration, Oral
1
2012
874
0.020
Why?
Severity of Illness Index
1
2018
2974
0.020
Why?
Aneuploidy
1
2010
91
0.020
Why?
Mice, Inbred Strains
1
2010
397
0.020
Why?
Interleukin-4
1
2010
207
0.020
Why?
Xenograft Model Antitumor Assays
1
2012
939
0.020
Why?
Antioxidants
1
2012
550
0.020
Why?
Disease-Free Survival
1
2010
779
0.020
Why?
Kaplan-Meier Estimate
1
2010
975
0.020
Why?
Proportional Hazards Models
1
2010
1344
0.010
Why?
Cross-Sectional Studies
1
2018
6011
0.010
Why?
Asia
1
2006
70
0.010
Why?
Dose-Response Relationship, Drug
1
2010
2030
0.010
Why?
Skin
1
1991
759
0.010
Why?
Databases, Nucleic Acid
1
2005
39
0.010
Why?
England
1
2006
111
0.010
Why?
Enzymes
1
2005
60
0.010
Why?
Age Distribution
1
2006
406
0.010
Why?
Case-Control Studies
1
2012
3660
0.010
Why?
Sex Distribution
1
2006
390
0.010
Why?
Species Specificity
1
2005
547
0.010
Why?
Cytokines
1
2012
2087
0.010
Why?
Cluster Analysis
1
2005
502
0.010
Why?
DNA Replication
1
2005
251
0.010
Why?
Apoptosis
1
2012
2454
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2005
751
0.010
Why?
Age Factors
1
2011
3372
0.010
Why?
Antibodies, Monoclonal
1
2010
1514
0.010
Why?
Body Weight
1
2006
976
0.010
Why?
Models, Statistical
1
2006
677
0.010
Why?
Young Adult
1
2018
14437
0.010
Why?
Risk Assessment
1
2010
3784
0.010
Why?
Time Factors
1
2010
7173
0.010
Why?
Retrospective Studies
1
2016
17561
0.010
Why?
Echocardiography, Transesophageal
1
1998
132
0.010
Why?
Infant
1
2006
10195
0.010
Why?
Culture Techniques
1
1991
66
0.010
Why?
Diabetes Mellitus, Type 2
1
2006
2627
0.010
Why?
Child, Preschool
1
2006
12017
0.000
Why?
Reference Values
1
1991
800
0.000
Why?
Diabetes Mellitus, Type 1
1
2006
3952
0.000
Why?
Adolescent
1
2006
22826
0.000
Why?
Child
1
2006
22980
0.000
Why?
Merrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)